Dendritic Cells Archive - Seite 69 von 106 - IOZK

Prostate cancer immunotherapy

2011-06-23/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-06-23 / Clin. Cancer Res. 2011 Aug;17(16):5233-8

Dendritic cell (DC) vaccination with low dose temozolomide phase I/II trial in melanoma patients: Preliminary data on peripheral blood regulatory t-cells (Treg) and DC-TEM8 expression modulations.

2011-06-17/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-06-17 / J Clin Oncol 29: 2011 (suppl; abstr e13029)

Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study

2011-06-17/in Dendritic Cells, International Publications, NSCLC /von 2011-06-17 / J. Exp. Clin. Cancer Res. 2011 Jun;30:65

Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer

2011-06-17/in Dendritic Cells, International Publications, NSCLC /von 2011-06-17 / Cancer Immunol. Immunother. 2011 Oct;60(10):1497-502

Sipuleucel-T: autologous cellular immunotherapy for men with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer

2011-06-15/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-06-15 / J Cancer 2011;2:357-9

Recent advances in immunotherapy for the treatment of prostate cancer

2011-06-15/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-06-15 / Expert Opin Biol Ther 2011 Aug;11(8):997-1009

Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research

2011-06-15/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-06-15 / Clin. Cancer Res. 2011 Jun;17(12):3884-91

Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus.

2011-06-06/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2011-06-06 / J Clin Oncol 29: 2011 (suppl; abstr 2508)

Pilot immunotherapy trial in high-risk pediatric sarcomas.

2011-06-05/in Dendritic Cells, Soft Tissue Sarcoma /von 2011-06-05 / J Clin Oncol 29: 2011 (suppl; abstr 9541)

Results of a phase I/II clinical trial of BPX-101, a novel drug-activated dendritic cell (DC) vaccine for metastatic castration-resistant prostate cancer (mCRPC).

2011-06-05/in Dendritic Cells, International Publications, Prostate Cancer /von 2011-06-05 / J Clin Oncol 29: 2011 (suppl; abstr 4670)